These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36338998)

  • 41. Multi-omics analysis reveals prognostic and therapeutic value of cuproptosis-related lncRNAs in oral squamous cell carcinoma.
    Li X; Zhou W; Zhu C; Liu J; Ming Z; Ma C; Li Q
    Front Genet; 2022; 13():984911. PubMed ID: 36046246
    [No Abstract]   [Full Text] [Related]  

  • 42. Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma.
    Zhu H; Mao F; Wang K; Feng J; Cheng S
    Front Genet; 2022; 13():972212. PubMed ID: 36212138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy.
    Wang XX; Wu LH; Ji H; Liu QQ; Deng SZ; Dou QY; Ai L; Pan W; Zhang HM
    Front Mol Biosci; 2022; 9():1001788. PubMed ID: 36250008
    [No Abstract]   [Full Text] [Related]  

  • 44. The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer.
    Li J; Wu F; Li C; Sun S; Feng C; Wu H; Chen X; Wang W; Zhang Y; Liu M; Liu X; Cai Y; Jia Y; Qiao H; Zhang Y; Zhang S
    Front Genet; 2022; 13():977322. PubMed ID: 36226193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cuproptosis-related lncRNAs as potential biomarkers of AML prognosis and the role of lncRNA HAGLR/miR-326/CDKN2A regulatory axis in AML.
    Du A; Yang Q; Luo X
    Am J Cancer Res; 2023; 13(9):3921-3940. PubMed ID: 37818049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
    He Y; Ye Y; Tian W; Qiu H
    Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
    [No Abstract]   [Full Text] [Related]  

  • 47. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
    Chen Y
    Front Genet; 2022; 13():912037. PubMed ID: 35937995
    [No Abstract]   [Full Text] [Related]  

  • 49. Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma.
    Huili Y; Nie S; Zhang L; Yao A; Liu J; Wang Y; Wang L; Cao F
    Front Genet; 2022; 13():958547. PubMed ID: 36072656
    [No Abstract]   [Full Text] [Related]  

  • 50. Cuproptosis-Mediated Patterns Characterized by Distinct Tumor Microenvironment and Predicted the Immunotherapy Response for Gastric Cancer.
    Wang XX; Deng SZ; Wu LH; Liu QQ; Zheng G; Du K; Dou QY; Zheng J; Zhang HM
    ACS Omega; 2023 Mar; 8(12):10851-10862. PubMed ID: 37008098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer.
    Wu X; Zhang Y; Liang G; Ye H
    Front Pharmacol; 2023; 14():1199883. PubMed ID: 37529698
    [No Abstract]   [Full Text] [Related]  

  • 52. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Hypoxia-Related Long Non-Coding RNAs Signature Associated With Prognosis in Lower-Grade Glioma.
    Feng Q; Qian C; Fan S
    Front Oncol; 2021; 11():771512. PubMed ID: 34869006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of an Immune-Related LncRNA Prognostic Signature for Glioma.
    Cao Y; Zhu H; Tan J; Yin W; Zhou Q; Xin Z; Wu Z; Jiang Z; Guo Y; Kuang Y; Li C; Zhao M; Jiang X; Peng J; Ren C
    Front Genet; 2021; 12():678436. PubMed ID: 34194477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma.
    Yu W; Huo H; You Z; Lu R; Yao T; Huang J
    Front Genet; 2022; 13():982888. PubMed ID: 36160008
    [No Abstract]   [Full Text] [Related]  

  • 56. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma.
    Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z
    BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas.
    Ye L; Xu Y; Hu P; Wang L; Yang J; Yuan F; Wang Y; Zhang C; Tian D; Chen Q
    Front Mol Neurosci; 2021; 14():720899. PubMed ID: 34776862
    [No Abstract]   [Full Text] [Related]  

  • 58. Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma.
    Cong T; Luo Y; Liu Y; Yang C; Yang H; Li Y; Li J; Li X
    Front Genet; 2022; 13():1000997. PubMed ID: 36276933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB.
    Li M; Nurzat Y; Huang H; Min P; Zhang X
    Front Genet; 2023; 14():1028044. PubMed ID: 36816017
    [No Abstract]   [Full Text] [Related]  

  • 60. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.